Werewolf Therapeutics Inc (HOWL)

Apr 03, 2026

HOWL Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Apr 01, 2026

Investment Report: Is now the right time to enter Werewolf Therapeutics IncWeekly Trend Recap & Capital Efficient Trading Techniques - baoquankhu1.vn

Apr 01, 2026

Apr 01, 2026

Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price - TipRanks

Apr 01, 2026

Apr 01, 2026

HOWL Forecast, Price Target & Analyst Ratings | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill

Apr 01, 2026

Mar 31, 2026

HOWL PE Ratio & Valuation, Is HOWL Overvalued - Intellectia AI

Mar 31, 2026

Mar 31, 2026

HOWL Should I Buy - Intellectia AI

Mar 31, 2026

Mar 31, 2026

Aug Action: Is now the right time to enter Werewolf Therapeutics Inc2026 Technical Patterns & Accurate Buy Signal Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 29, 2026

Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN

Mar 29, 2026

Mar 27, 2026

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - bitget.com

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - tipranks.com

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings - AlphaStreet

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics Reports 2025 Financial Results and Advances Cancer Therapy Clinical Pipeline - geneonline.com

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics (HOWL) faces going‑concern risk while IL‑2 and IL‑12 candidates show early responses - Stock Titan

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics 10-K: Revenue $0M, Net Loss $(60.82)M - TradingView

Mar 27, 2026

Mar 27, 2026

Earnings Scheduled For March 27, 2026 - Benzinga

Mar 27, 2026

Mar 27, 2026

HOWL: Strategic review underway with improved financials and continued progress in oncology pipeline - TradingView

Mar 27, 2026

Mar 27, 2026

Werewolf Therapeutics (NASDAQ: HOWL) cuts 2025 loss and launches strategic review - Stock Titan

Mar 27, 2026

Mar 25, 2026

Aug Drivers: Is Werewolf Therapeutics Inc a speculative investment2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Biotech 'Lowballed' Landlord On Lease Exit, Suit Says - Law360

Mar 25, 2026

Mar 24, 2026

Werewolf Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 24, 2026

Mar 23, 2026

HOWL Stock Price, Quote & Chart | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill

Mar 23, 2026

Mar 18, 2026

Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Michael J. Urban Net Worth (2026) - gurufocus.com

Mar 17, 2026

Mar 17, 2026

Werewolf Therapeutics (HOWL) eyes 2026 catalysts following FDA guidance and encouraging INDUKINE results - MSN

Mar 17, 2026

Mar 17, 2026

RSI Check: Is Werewolf Therapeutics Inc stock trending bullishTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Analyst Downgrade: Is now the right time to enter Werewolf Therapeutics IncLayoff News & Real-Time Volume Triggers - baoquankhu1.vn

Mar 16, 2026

Mar 13, 2026

Werewolf Therapeutics (HOWL) finance VP reports stock and option holdings on Form 3 - Stock Titan

Mar 13, 2026

Mar 13, 2026

Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN

Mar 13, 2026

Mar 12, 2026

Werewolf Therapeutics (HOWL) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 12, 2026

Mar 07, 2026

Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN

Mar 07, 2026

Mar 05, 2026

Published on: 2026-03-05 15:55:35 - baoquankhu1.vn

Mar 05, 2026

Mar 05, 2026

Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits

Mar 05, 2026

Mar 04, 2026

HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Mar 03, 2026

Mar 02, 2026

HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 02, 2026

Mar 02, 2026

Is now the right time to enter Werewolf Therapeutics IncTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn

Mar 02, 2026

Feb 27, 2026

Werewolf Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Feb 27, 2026

Feb 25, 2026

Werewolf Therapeutics announces plan to explore strategic alternatives - MSN

Feb 25, 2026

Feb 25, 2026

Werewolf Therapeutics explores sale and strategic alternatives - Investing.com India

Feb 25, 2026

Feb 25, 2026

Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - The Manila Times

Feb 25, 2026

Feb 24, 2026

Werewolf Therapeutics Begins Strategic Alternatives Review Process - TipRanks

Feb 24, 2026

Feb 24, 2026

Werewolf Therapeutics (HOWL) starts review of strategic options with Piper Sandler - Stock Titan

Feb 24, 2026

Feb 24, 2026

Werewolf Therapeutics explores sale and strategic alternatives By Investing.com - Investing.com South Africa

Feb 24, 2026

Feb 24, 2026

Werewolf to Explore Strategic Alternatives, Engages Piper Sandler as Exclusive Advisor - TradingView

Feb 24, 2026

Feb 24, 2026

Levels Update: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Feb 24, 2026

Feb 21, 2026

HOWL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 21, 2026

Feb 17, 2026

Why Werewolf Therapeutics Inc. stock could rally in 2025Portfolio Gains Summary & Smart Swing Trading Techniques - mfd.ru

Feb 17, 2026

Feb 16, 2026

IPO Launch: Does Werewolf Therapeutics Inc have strong EBITDA margins2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn

Feb 16, 2026

Feb 14, 2026

Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada

Feb 14, 2026